INTRODUCTION
Since James first described in 1959 the placement and use of umbilical artery catheters (UAC), arterial lines have become routine practice in neonatal intensive care units for arterial blood gases and blood pressure monitoring. 1 This procedure is usually accomplished easily and safely, but in some cases, complications can occur. With the low-position catheters and with the peripheral arterial lines, the most frequent complication is episodes of blanching and cyanosis of the extremities. 2 This peripheral vasospasm caused by artery catheterization occurs in <20% of cases and, in the case of UAC, can be treated with reflex vasodilation by warming of the contralateral leg. If the cyanosis or the blanching continues or gets worse over the next 15 minutes, the catheter should be removed. This method of treatment is not always successful, and prolonged ischemia can lead to tissue necrosis and the loss of large amounts of tissue, requiring reconstructive surgery. 3 There have been two case reports regarding the use of topical 2% nitroglycerin ointment to reverse severe tissue ischemia secondary to complications with indwelling artery catheters and from extravasation of dopamine in neonates. 4, 5 In both cases, the infants treated with topical nitroglycerin had complete resolution of peripheral tissue ischemia without secondary effects. We are reporting now two infants with peripheral ischemia secondary to umbilical arterial catheterization and one case of hand ischemia secondary to radial artery line that had not responded to conventional management and were successfully treated with 2% nitroglycerin ointment.
CASE REPORTS Case 1
Baby boy F was a 1620-g infant born at 30 weeks' gestation to a 29-year-old mother, gravida 2, para 0, abortion 1. The mother received betamethasone for preterm labor, and clindamycin and gentamicin for chorioamnionitis. Delivery was by C-section for fetal distress. APGAR scores were 8 and 9 at 1 and 5 minutes, respectively.
Physical exam on admission to the neonatal intensive care unit showed an infant in significant respiratory distress, hypotensive, and with poor peripheral perfusion. The infant had respiratory distress syndrome and was treated with surfactant and high-frequency ventilation. Hypotension was treated with numerous boluses of normal saline, dopamine, and dobutamine.
A 5-French umbilical arterial line (UAL) was inserted on admission and its correct position was verified by X-ray. Twenty minutes later, the entire left leg, penis, and scrotum blanched and then turned blue and, therefore, the UAL was removed ( Figure 1A) . Then a 3.5-French UAL was inserted in the other artery. However, there was persistent poor perfusion of the left leg and the left femoral pulse was not palpable. On Doppler exam, the left femoral and tibial pulses were weak compared to the right pulses. The left leg was elevated, and heat was applied to the contralateral leg. No improvement was noted so the infant received heparin and was given 20 ml/kg dextran, i.v., also without success.
After 1 hour of unsuccessful conventional management, nitroglycerin ointment was applied over the left femoral artery and at three other locations along the left leg ( Figure 1 , B and C). Within 30 minutes, the left upper leg became well perfused, and within 45 minutes, the entire left leg had normal perfusion with brisk capillary refill ( Figure 1D ). Blood pressure and heart rate remained 
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stable during treatment with nitroglycerin. No further treatment was administered.
Case 2
Baby girl W was born to a 25-year-old mother, gravida 3, para 1, abortion 1, at 25 5/7 weeks' gestational age. Delivery was by C-section for breech presentation. The infant was intubated at 5 minutes of life. APGAR scores were 7 and 7 at 1 and 5 minutes, respectively. Exam on admission to neonatal intensive care unit was consistent with a 25-week infant. An umbilical venous line was placed without complication. A low UAL was placed and its position verified by X-ray upon admission. However, the right leg blanched 2 hours after UAC placement, so the catheter was removed. The infant's right leg was elevated, and the left leg was warmed for approximately 90 minutes, but the right leg continued to have poor perfusion. Femoral pulse was not palpable and the toes were progressively cooler, cyanotic, and stiff. Doppler showed no flow from femoral region to dorsalis pedis. Because there was no improvement and the infant's clinical condition had deteriorated, 4 mm/kg 2% nitroglycerin ointment was applied over the right femoral artery and at three other locations along the right leg. Perfusion improved dramatically and, within 45 minutes, there was full recovery of color and pulses. No hypotension or tachycardias were noted during this time, and no further treatment was required.
Case 3
Baby boy R was a 10-day-old, 660-g, 23 6/7 weeks' gestational age infant born to a 25-year-old mother, gravida 3, para 0, abortion 2. The baby had been delivered with double footling breech by vaginal delivery. Maternal prenatal laboratories included a positive HBsAg (active hepatitis B) and positive group B Streptococcus. Pregnancy was complicated by premature labor and maternal temperature up to 100.8 8F. After delivery, the infant was immediately intubated and the first dose of surfactant was given. Baby was dried and stimulated, with improvement in color and tone at 5 minutes. APGAR scores were 3, 5, and 6 at 1, 5, and 10 minutes, respectively. The second and third doses of surfactant were subsequently given upon admission to the neonatal intensive care unit. A blood culture was drawn and the patient was started on ampicillin and gentamicin for prophylaxis against group B Streptococcus exposure. The baby was also given HBIG and hepatitis B vaccine for maternal positive hepatitis BsAg. Blood culture was negative and antibiotics discontinued at 48 hours of age. The infant remained on stable ventilator settings until DOL 7, when he was noted to have free air on abdominal X-ray; he was taken to surgery, had an ileostomy for isolated perforation in the ileum, and was able to wean ventilatory support after the intervention.
On DOL 10, the baby was noted to have pale left hand fingers; the left radial arterial line that had been placed in DOL 1 was removed. The radial pulse was absent and assessment of arterial flow by Doppler stethoscope was negative. The left arm was elevated and the contralateral arm was warmed. After 1 hour, the fingers were still pale and rigid, and some had progressed to a bluish discoloration. Because the left hand had clinically worsened, a ribbon of 2% nitroglycerin ointment was applied to the palm, the base of the fingers, and the radial artery area. The perfusion of the fingers improved within 1/2 hour and there was full recovery of color. During this time, a mild decrease in mean arterial blood pressure occurred, but no intervention was given because the blood pressure returned to baseline values within 30 minutes. No further treatment was administered.
DISCUSSION
In this case report, we describe for the first time the use of topical nitroglycerin ointment to reverse ischemia of the lower extremities secondary to UAC. We also report the use of this topical vasodilator to treat hand ischemia secondary to radial catheterization. In all three cases, conservative treatment had proved unsuccessful, but local application of 2% nitroglycerin at a dose of 4 mm/kg induced rapid improvement of perfusion with no side effects.
Invasive hemodynamic monitoring and arterial access for blood sampling are widely used in the care of critically ill neonates. The insertion of arterial catheters mechanically damages the vascular endothelium, exposing subendothelial tissue and collagen to the circulating blood. Platelets then adhere and aggregate, releasing adenosine diphosphate and thromboxane A2 (a platelet stimulator and a very potent vasoconstrictor). These events may lead to vasospasm around the catheter insertion site, complete occlusion, and tissue ischemia.
Although UACs have about one half the complication rate of umbilical vein catheters, they are still responsible for considerable morbidity. Among the complications extensively described in the literature, the obstruction to blood flow from thrombi, emboli, or vasospasm is one of the potentially more serious complications. 6 -8 The incidence of these complications is not surprising because the vessels are usually very small and the infants who receive arterial lines are usually very ill with decreased cardiac output, dehydration, and polycythemia. Infants with leg blanching or discoloration after UAL is placed appear to be at a greater risk for thrombotic complications than those without such symptoms. 6 In a review of 129 infants who underwent autopsy and had a history of umbilical catheterization, Joseph et al.
14 reported 25 infants (19.3%) who had developed arterial thrombosis. Among them, 14 infants had severe complications secondary to the thrombosis (gangrene, renal, and/or gastro-intestinal involvement). Five infants had died of these complications. Of note, the authors report that the sequelae had been clinically unexpected in the majority of babies and that comparison of neonatal factors revealed no significant differences between the group with sequelae and those without. 13 In the case of arterial thrombosis, vasodilation of the vessel containing the thrombus may prevent further ischemia. The usual treatment of ischemic injuries includes removal of the catheter, elevation of the affected limb, and warming of the opposite leg/arm. This method is not always successful, and tissue necrosis and loss may follow.
Percutaneous catheterization of peripheral arteries (radial, posterior tibial, temporal, and so forth) has been advocated by some authors as a safer and reliable alternative to umbilical catheterization. 9, 10 Most of the reports in the literature have shown that even though complications are rare, they can range from areas of skin necrosis and localized infections to ischemic necrosis of fingertips and hand, and gangrene.
Since Murrell described the use of nitroglycerin in 1879, this compound has mainly been used for acute relief and prophylactic management of angina pectoris. Nitroglycerin is an organic nitrate of which the primary pharmacological action is relaxation of vascular smooth muscle, resulting in generalized vasodilation. In recent years, interest in the specific mechanism of action and therapeutic application of this compound has been reawakened because organic nitrates have been found to generate their pharmacological action by the production of nitric oxide (NO).
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In this way, nitroglycerin would be viewed as a prodrug of endogenous NO, although its structure differs from that of endogenous substrate L -arginine, and nitroglycerin does not use the enzyme NO synthase for NO generation. The enzyme or enzymes involved in this process still need to be identified. But it is possible that these differences in the synthesis of NO may have a very important role in the therapeutic application of organic nitrates, i.e., disease states that can alter endogenous production of NO may not cause the same effect in the ability of organic nitrates to generate NO. The NO produced in this metabolic pathway activates guanylate cyclase, producing cyclic guanosine monophosphate, which leads to vasodilation.
Nitroglycerin is well absorbed across intact skin, delivering the highest dose to the area directly beneath. In addition to vasodilation, nitroglycerin can increase collateral circulation to areas of peripheral ischemia. The amount of nitroglycerin reaching the circulation varies directly with the size of the area of application and the amount of ointment applied. In this respect, the initial dose of 2% nitroglycerin ointment used was calculated on the basis of weight, at 4 mm/kg, which is equivalent to 0.2 to 0.5 g/kg per minute given intravenously. 12 The onset of action is within 1 hour, and the hemodynamic effects last up to 6 hours. Regarding acute toxicity, adverse effects from organic nitrates overdose are extensions of their pharmacological action, namely vasodilation, venous pooling, reduced cardiac output, and hypotension. 13 However, in spite of the small number of infants treated, we did not encounter major side effects. We believe that this is due to the low initial dose of nitroglycerin we used. Repeated applications should be administered only if the desired local effect is not obtained and no adverse effects are present. For this reason, continuous monitoring of vital signs is required.
Nitroglycerin offers the advantage of being given topically compared to other agents that must be injected, and if any of the above adverse effects mentioned occurs, the excess dose may be wiped away.
In summary, we feel that 2% nitroglycerin ointment can be useful and safe in the treatment of peripheral tissue ischemia secondary to umbilical and peripheral arterial catheters that do not respond to conservative treatment. Prospective studies are recommended to better assess dosing requirements, efficacy, and safety.
